These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18240853)

  • 21. Managing ADHD in children, adolescents, and adults with comorbid anxiety.
    CME Institute of Physicians Postgraduate Press, Inc
    J Clin Psychiatry; 2007 Mar; 68(3):451-62. PubMed ID: 17388718
    [No Abstract]   [Full Text] [Related]  

  • 22. Attention-deficit hyperactivity and conduct disorder: comorbidity and implications for treatment.
    Abikoff H; Klein RG
    J Consult Clin Psychol; 1992 Dec; 60(6):881-92. PubMed ID: 1360990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attention deficit hyperactivity disorder in adults. An overview].
    Sobanski E; Alm B
    Nervenarzt; 2004 Jul; 75(7):697-715; quiz 716. PubMed ID: 15221066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
    Rohatgi RK; Bos JM; Ackerman MJ
    Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot study.
    Arvidsson M; Dahl ML; Franck J; Wiig EH; Nielsen NP
    Nord J Psychiatry; 2019 Feb; 73(2):118-124. PubMed ID: 30861357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on Attention-Deficit/Hyperactivity Disorder.
    Soileau EJ
    Adolesc Med State Art Rev; 2014 Aug; 25(2):502-19. PubMed ID: 27132328
    [No Abstract]   [Full Text] [Related]  

  • 28. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
    Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
    Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical review of outcomes of the multimodal treatment study of children with attention-deficit/hyperactivity disorder (MTA).
    Murray DW; Arnold LE; Swanson J; Wells K; Burns K; Jensen P; Hechtman L; Paykina N; Legato L; Strauss T
    Curr Psychiatry Rep; 2008 Oct; 10(5):424-31. PubMed ID: 18803917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep characteristics of children and adolescents with attention deficit-hyperactivity disorder.
    Gruber R
    Child Adolesc Psychiatr Clin N Am; 2009 Oct; 18(4):863-76. PubMed ID: 19836693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?
    Volkow ND; Swanson JM
    Am J Psychiatry; 2008 May; 165(5):553-5. PubMed ID: 18450933
    [No Abstract]   [Full Text] [Related]  

  • 35. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G; Vannucchi G
    Expert Opin Pharmacother; 2015; 16(14):2193-204. PubMed ID: 26364896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH
    Am J Addict; 2007; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy in ADHD. Guidelines for prescribing stimulant medications in young children.
    August GJ; Realmuto GM
    Minn Med; 2000 Jun; 83(6):45-6. PubMed ID: 10881573
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment strategies for co-occurring ADHD and substance use disorders.
    Mariani JJ; Levin FR
    Am J Addict; 2007; 16 Suppl 1(Suppl 1):45-54; quiz 55-6. PubMed ID: 17453606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.
    Froehlich TE; Fogler J; Barbaresi WJ; Elsayed NA; Evans SW; Chan E
    Clin Pharmacol Ther; 2018 Oct; 104(4):619-637. PubMed ID: 30053315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study.
    Barkley RA; Fischer M; Smallish L; Fletcher K
    Pediatrics; 2003 Jan; 111(1):97-109. PubMed ID: 12509561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.